Gilead Sciences, Inc. (GILD) Stock Price, Quote, Charts & Tips
Gilead Sciences, Inc. (GILD) Stock Price, Quote, Charts & Tips
The price of Gilead Sciences, Inc. is $107.00, a -4.94% change over the last 7 days. View Gilead Sciences, Inc.’s price chart, history, ratings, and buy/sell tips.
Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who may pay to be displayed in certain positions on certain pages, or may compensate us for referring users to their services. While our reviews and assessments of each product are independent and unbiased, the order in which brands are presented and the placement of offers may be impacted and some of the links on this page may be affiliate links from which we earn a commission. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
| 24h Change | -$0.42 |
|---|---|
| 24h High | $69.00 |
| 24h Low | $68.07 |
| Market cap | $133.35B |
| P/E Ratio | 289.41 |
| Dividend yield | 0.0295% |
| Earnings per share | $0.37 |
| 52 Week High | $119.12 |
| 52 Week Low | $59.82 |
Advanced chart
Profile
Technical analysis & Fundamental data
About Gilead
Copy link to sectionWhat is Gilead?
Copy link to sectionGilead Sciences is a biopharmaceutical company specialising in various therapies for several diseases. Founded in 1987 and headquartered in Foster City, California, Gilead is best known for its research, development, and commercialisation of medicines for diseases including HIV/AIDS, viral hepatitis, cancer, and inflammatory diseases.
How does Gilead make money?
Copy link to sectionIt makes money by selling pharmaceutical products. This includes medicines and other therapies. It has four main therapeutic areas, including HIV/AIDS, liver diseases, oncology, and respiratory diseases.
It also generates revenue from licensing agreements and partnerships with other companies in the biopharma industry. Gilead also has a pipeline of drugs in the development stage, which can potentially add to its revenue if approved.
What is Gilead’s best selling product?
Copy link to sectionIts best selling product is Biktarvy, which is a daily tablet for the treatment of HIV-1 infection. In quarter 4 of 2022, Biktarvy generated $1.95 billion in net product sales, a 9% increase from the previous year. Biktarvy is the most prescribed HIV regimen in the United States.
The company also has a range of other top-selling therapies, including Truvada (for HIV), Veklury (for COVID-19), and Yescarta (for cancer treatment.
Who are the key executives at Gilead?
Copy link to sectionDaniel O’Day is Gilead’s currency chairman and chief executive officer. Here are some other members of its executive team.
- Daniel P. O’Day. Chairman & CEO
- Andrew D. Dickinson. Exec. VP & CFO
- Deborah H. Telman. Exec. VP of Corp. Affairs, Gen. Counsel & Corp.
- Johanna Mercier. Chief Commercial Officer
- Merdad V. Parsey M.D., Ph.D. Chief Medical Officer
- Sandra Patterson. Sr. VP, Corp. Controller & Principal Accounting Officer
- Jacquie Ross C.F.A.. VP of Investor Relations
- Jyoti K. Mehra Exec. VP of HR
- Michael Quigley Ph.D. Sr. VP of Research Biology
- Linda Slanec Higgins Ph.D. Sr. VP & Head of External Innovation
Where can I buy shares in Gilead?
Copy link to sectionYou can buy Gilead stock on a stock trading platform. These platforms are extremely simple to use but there are different options to suit your specific needs. If you are a first-time investor you might want to use a trading platform for beginners, while if you plan on doing a lot of trading from your phone, a stock trading app might be best.
Are there any other ways to invest in Gilead?
Copy link to sectionThe simplest way to invest in Gilead is to buy shares through a stock broker. However, you can also invest through an ETF or a fund. The best ETFs allow you to invest in the stock market more generally rather than focus on one company.
Gilead is part of the Nasdaq index, so you can invest in an ETF that tracks that index, or choose a pharmaceutical ETF that lets you own a basket of related stocks from the same industry.
More about the GILD price
Copy link to sectionWhat is the Gilead stock price today?
Copy link to sectionThe GILD stock price today is currently $80.36 as of 27 March, 2023. The price of Gilead is up 35.24% over the past 52 weeks. You can use the live Gilead stock chart to track the NASDAQ:GILD price in real time above, or compare the Gilead value today to its past performance using the Gilead financials tab at the top of this page.
What is the 52-week low for Gilead stock?
Copy link to sectionThe 52-week low for Gilead stock is $57.17. GILD stock is currently 40.91% above the 52-week low.
What is the 52-week high for Gilead stock?
Copy link to sectionThe 52-week high for Gilead stock is $98.74. GILD stock is currently 10.24%below the 52-week high.
What is the stock forecast for Gilead?
Copy link to sectionThe average Gilead stock forecast has a price target of $90.15 by the end of 2023. Gilead’s latest financial results, the broader economic outlook, and the amount of competition in the industry all influence these forecasts.
It’s best to take analyst forecasts with a grain of salt but you can use their estimates to help you understand the weight of opinion about a stock.
More stock guides
Copy link to sectionFAQs
Copy link to sectionHow much is Gilead worth?
When did GILD stock go public?
Who owns the most shares in Gilead?
Who are Gilead’s biggest competitors?
Has GILD stock split?
When are Gilead’s earnings?
Does Gilead pay a dividend?
Latest Gilead Sciences, Inc. news, trading ideas & analysis
